Global Wound Biologics Market 2016-2020

  • ID: 3616182
  • Report
  • Region: Global
  • 54 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Acelity
  • BioDlogics
  • Cytori Therapeutics
  • Intercytex
  • Molyncke Health Care
  • Organogenesis
  • MORE
About Wound Biologics

Mechanical, chemical, thermal, and radiogenic damages can cause cuts, tears, and punctures in the skin, blood vessels, nerves, muscles, internal organs, bones, and joints. Wounds are of two types: acute and chronic. The reparative process in acute wounds occurs at a predictable and expected rate leading to faster healing, while it fails to occur in a predictable amount of time in chronic wounds.

Biologic wound healing process helps re-establish the innate repair mechanisms and may involve the application of biological agents such as plant-derived active biomolecules having antimicrobial, antioxidant, and anti-inflammatory attributes. Biologic dressings prevent evaporative water loss, protein and electrolyte loss, heat loss, and wound contamination. Wound biologics such as granular wound beds permit autolytic debridement for the healing process.

The analysts forecast the global wound biologics market to grow at a CAGR of 20.63% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global wound biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:
- Skin substitutes
- Growth factors

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Wound Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Acelity
- Integra LifeSciences
- Organogenesis
- Smith & Nephew

Other prominent vendors
- Avita Medical
- BioDlogics
- ConvaTec
- Cytori Therapeutics
- Intercytex
- MacroCure
- Molyncke Health Care
- Nuo Therapeutics
- Osiris Therapeutics
- Regenerys

Market drivers
- Prevalence of chronic diseases
- For a full, detailed list, view the full report

Market challenges
- Limited availability of clinical data
- For a full, detailed list, view the full report

Market trends
- Advances in technology
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acelity
  • BioDlogics
  • Cytori Therapeutics
  • Intercytex
  • Molyncke Health Care
  • Organogenesis
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global wound biologics market by skin substitutes
  • Global wound biologics market by growth factors
PART 07: Geographical segmentation
  • Wound biologics market in Americas
  • Wound biologics market in EMEA
  • Wound biologics market in APAC
PART 08: Market drivers
  • Prevalence of chronic diseases
  • Availability of different skin substitutes
  • Rise in geriatric population
PART 09: Impact of drivers

PART 10: Market challenges
  • Limited availability of clinical data
  • Availability of alternatives
  • Stringent regulatory approval process
PART 11: Impact of drivers and challenges

PART 12: Market trends
  • Advances in technology
  • Increase in pipeline products
  • Demand for combination dressings
  • Emergence of new treatment options
PART 13: Vendor landscape
  • Competitive scenario
  • Key news
  • Mergers and acquisitions
  • Market share analysis 2015
  • Smith & Nephew
  • Organogenesis
  • Acelity
  • Integra LifeSciences
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
PART 15: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Stages of wound healing
Exhibit 03: Types of wounds
Exhibit 04: Global wound biologics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global wound biologics market segmentation by product
Exhibit 07: Global wound biologics market by skin substitutes 2015-2020 ($ millions)
Exhibit 08: Growth factors involved in wound healing
Exhibit 09: Global wound biologics market by growth factors 2015-2020 ($ millions)
Exhibit 10: Global wound biologics market segmentation by geography 2015
Exhibit 11: Wound biologics market in Americas 2015-2020 ($ millions)
Exhibit 12: Wound biologics market in EMEA 2015-2020 ($ millions)
Exhibit 13: Wound biologics market in APAC 2015-2020 ($ millions)
Exhibit 14: Global wound biologics market segmentation by geography 2015-2020 ($ millions)
Exhibit 15: Global wound biologics market segmentation by geography 2015-2020
Exhibit 16: Different commercially available skin substitutes
Exhibit 17: Impact of drivers
Exhibit 18: Impact of drivers and challenges
Exhibit 19: Middle- and late-stage wound biologics in pipeline
Exhibit 20: Ranking of vendors 2015
Exhibit 21: Market share of vendors 2015
Exhibit 22: Smith & Nephew: Business segmentation by revenue 2014
Exhibit 23: Smith & Nephew: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 24: Smith & Nephew: Key takeaways
Exhibit 25: Organogenesis: Key takeaways
Exhibit 26: Acelity: Business segmentation by revenue 2014
Exhibit 27: Acelity: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Acelity: Key takeaways
Exhibit 29: Integra LifeSciences: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Acelity
  • BioDlogics
  • Cytori Therapeutics
  • Intercytex
  • Molyncke Health Care
  • Organogenesis
  • MORE
New Report Released: - Global Wound Biologics Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Wound Biologics Market: Acelity, Integra LifeSciences, Organogenesis and Smith & Nephew.

Other Prominent Vendors in the market are: Avita Medical, BioDlogics, ConvaTec, Cytori Therapeutics, Intercytex, MacroCure, Molyncke Health Care, Nuo Therapeutics, Osiris Therapeutics and Regenerys.

Commenting on the report, an analyst from the research team said: “The growth of this market is driven by the rising demand for various biologics in advanced wound care segment. Products such as allografts and autografts have high efficacy rates, and these are used for healing chronic wounds such as diabetic foot ulcers and venous ulcers. The availability of a broad range of approved skin substitutes such as grafts, tissue scaffolds, and cell-based therapies are expected to increase its demand from physicians and patients during the forecast period.”

According to the report, chronic wounds such as diabetic foot ulcers, leg ulcers, and pressure ulcers lead to complications such as infections, ulceration, and insufficient blood supply and take longer duration for wound healing. This increases the demand for advanced wound care products such as skin substitutes and growth factors to improve the healing process, resulting in greater sales of these products.

Further, the report states that most of the wound biologics available in the market are regenerative medicine- and tissue engineering-based products. Procedures based on these products are risky, increasing the need for clinical trials to prove their safety and efficacy. Lack of clinical data for safety and efficacy of these products also hinders their use by physicians and surgeons.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Acelity
- Integra LifeSciences
- Organogenesis
- Smith & Nephew
- Avita Medical
- BioDlogics
- ConvaTec
- Cytori Therapeutics
- Intercytex
- MacroCure
- Molyncke Health Care
- Nuo Therapeutics
- Osiris Therapeutics
- Regenerys.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll